Risk factors for breakthrough COVID-19 in 15,804 UK adults after primary and booster doses of SARS-CoV-2 vaccines
View/ Open
Volume
60
DOI
10.1183/13993003.congress-2022.1700
ISSN
0903-1936
Metadata
Show full item recordAuthors
Vivaldi, G; Jolliffe, DA; Holt, H; Talaei, M; Tydeman, F; Shaheen, SO; Martineau, ARCollections
- Centre for Immunobiology [1099]